Publications

Science
Media
Other

Combined Deep Learning Algorithms Demonstrate That Both Computed Tomography Phenotype and Anatomical Biomarkers Are Predictive of Prognosis and Progression in Idiopathic Pulmonary Fibrosis

ATS Journals
May 16, 2025

Deep Learning Quantitative Computed Tomography Analysis in the Australian Idiopathic Pulmonary Fibrosis Registry

ATS Journals
May 16, 2025

Deep Learning-based Disease Severity Biomarkers on CT; Posthoc Analysis in a Phase 2a Placebo-controlled Study of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis

ATS Journals
May 16, 2025

Monte Carlo External Control Arm Generation Utilising Real-world Patient Data and Deep Learning-based Quantitative CT Metrics Demonstrates Treatment Effect in the Atlas IPF Trial

ATS Journals
May 16, 2025

Deep Learning-Based Short-Term Disease Progression Evaluation Supersedes Automated Baseline CT Phenotype in Predicting Outcomes in Idiopathic Pulmonary Fibrosis

ATS Journals
May 16, 2025

Deep Learning-Based Quantitative CT and CT Phenotype Classification Independently Predict Mortality in Idiopathic Pulmonary Fibrosis, a Prospective Observational Cohort Study

ATS Journals
May 16, 2025

Deep Learning-based Quantitative CT and Proteomics for Predicting Outcomes in Idiopathic Pulmonary Fibrosis

ATS Journals
May 16, 2025

Dose-Dependent Change of Inhaled Pirfenidone Seen in Lung Volume and Fibrosis Quantification in Patients With IPF: A Deep Learning Image-Based Analysis of Data From the ATLAS Phase 1b Trial

ATS Journals
May 16, 2025

Blue Journal Paper in IPF

ATS Journals
October 2, 2024

Characterisation of high responders in the AIR C21 Vicore study ERS abstract

ERS Journals
October 1, 2024

Automated vascular and fibrotic segmentations associated with IPF mortality ATS abstract

ATS Journals
September 30, 2024

Imaging adds to mortality prediction in IPF ATS abstract

ATS Journals
September 29, 2024

GLPG1205 ERS abstract

ERS Journals
September 28, 2024

Automated cohort selection ERS abstract

ERS Journals
September 26, 2024

Automated airway model in IPF ERS abstract

ERS Journals
September 25, 2024

The Potential for Deep Learning Technology in Clinical Trials

Journal of Clinical Studies
June 12, 2025

Rein Therapeutics and Qureight broaden life science collaboration

Business Weekly
May 6, 2025

How is deep learning imaging advancing drug discovery for fibrosis?

Drug Discovery World
April 28, 2025

The role of NHS Big Data and AI technology in unlocking the future of lung and heart disease treatment

pharmaphorum
March 24, 2025

Qureight and Remedy Cell to validate RC-0315 in Phase Ib trial for IPF

Clinical Trials Arena
March 13, 2025

Vicore Pharma to track lung fibrosis trial with Qureight's AI-powered imaging platform

FirstWord PHARMA
February 21, 2025

Qureight tech deployed in lung fibrosis clinical trial

Health Tech World
February 20, 2025

Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis

Pharma Focus Europe
February 11, 2025

Qureight and Avalyn launch strategic partnership in pulmonary fibrosis

PharmaTimes Online
February 6, 2025

Unravelling the most complex disease challenges in history: How AI startups are changing drug discovery

Startups Magazine
December 1, 2024

8 Questions by Playfair

Medium
October 2, 2024

Sifted Series A announcement

Sifted
October 1, 2024

UKTN Pitching to investors

UK Tech News
September 30, 2024

Cambridge Angels 5 Questions

Cambridge Angels
September 29, 2024

AstraZeneca adopts Qureight platform for IPF research

Cambridge Independent
September 28, 2024

Cambridge tech podcast

Cambridge Tech Podcast
September 27, 2024

Addressing inequalities in healthcare

Digital Health
September 26, 2024

Venturing forth Cambridge Judge Business School

University of Cambridge
September 25, 2024
No items found.